{"disease":{"id":"hormone-receptor-positive-hr-human-epidermal-growth-factor-receptor-2-negative-her2-negative-advanced-or-metastatic-breast-cancer-in-combination-with-fulvestrant-in-women-with-disease-progression-following-endocrine-therapy.md","name":"hormone receptor positive hr human epidermal growth factor receptor 2 negative her2 negative advanced or metastatic breast cancer in combination with fulvestrant in women with disease progression following endocrine therapy.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}